D.E. Shaw & Co’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.37M | Sell |
1,403,990
-197,334
| -12% | -$865K | ﹤0.01% | 2782 |
|
|
2025
Q4 | $8.29M | Buy |
1,601,324
+221,481
| +16% | +$1.14M | ﹤0.01% | 1911 |
|
|
2025
Q3 | $7.2M | Buy |
1,379,843
+892,171
| +183% | +$4.65M | ﹤0.01% | 1921 |
|
|
2025
Q2 | $1.87M | Buy |
487,672
+336,030
| +222% | +$869K | ﹤0.01% | 2783 |
|
|
2025
Q1 | $872K | Sell |
151,642
-36,941
| -20% | -$218K | ﹤0.01% | 3170 |
|
|
2024
Q4 | $941K | Sell |
188,583
-146,198
| -44% | -$750K | ﹤0.01% | 3239 |
|
|
2024
Q3 | $1.8M | Buy |
334,781
+12,843
| +4% | +$61.1K | ﹤0.01% | 2777 |
|
|
2024
Q2 | $1.07M | Sell |
321,938
-225,702
| -41% | -$884K | ﹤0.01% | 3164 |
|
|
2024
Q1 | $1.79M | Buy |
547,640
+287,584
| +111% | +$946K | ﹤0.01% | 2721 |
|
|
2023
Q4 | $913K | Buy |
260,056
+214,089
| +466% | +$661K | ﹤0.01% | 3194 |
|
|
2023
Q3 | $307K | Sell |
45,967
-30,013
| -40% | -$223K | ﹤0.01% | 3603 |
|
|
2023
Q2 | $637K | Sell |
75,980
-48,942
| -39% | -$482K | ﹤0.01% | 3316 |
|
|
2023
Q1 | $1.24M | Sell |
124,922
-222,947
| -64% | -$1.58M | ﹤0.01% | 3012 |
|
|
2022
Q4 | $2.42M | Sell |
347,869
-100,241
| -22% | -$573K | ﹤0.01% | 2782 |
|
|
2022
Q3 | $2.39M | Buy |
448,110
+174,769
| +64% | +$1.05M | ﹤0.01% | 2839 |
|
|
2022
Q2 | $1.09M | Buy |
273,341
+34,183
| +14% | +$118K | ﹤0.01% | 3579 |
|
|
2022
Q1 | $1.06M | Buy |
239,158
+202,930
| +560% | +$808K | ﹤0.01% | 3865 |
|
|
2021
Q4 | $145K | Buy |
36,228
+21,947
| +154% | +$167K | ﹤0.01% | 4977 |
|
|
2021
Q3 | $125K | Sell |
14,281
-942
| -6% | -$8.64K | ﹤0.01% | 4678 |
|
|
2021
Q2 | $172K | Sell |
15,223
-2,929
| -16% | -$35.2K | ﹤0.01% | 4473 |
|
|
2021
Q1 | $216K | Buy |
+18,152
| New | +$209K | ﹤0.01% | 3822 |
|
|
2019
Q4 | – | Sell |
-18,111
| Closed | -$95K | – | 3938 |
|
|
2019
Q3 | $95K | Buy |
18,111
+7,007
| +63% | +$37.7K | ﹤0.01% | 3702 |
|
|
2019
Q2 | $67K | Buy |
+11,104
| New | +$83.6K | ﹤0.01% | 3573 |
|
Other funds holding ALDX
KCM
VCM
KCM
6CM
